Skip to main content
Recall Canary
Amlodipine and Olmesartan Medoxomil Tablets
← Back to all recalls
DRUG RECALLMODERATE

Amlodipine and Olmesartan Medoxomil Tablets

Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, due to failed dissolution specifications.

What to do

Contact your healthcare provider or pharmacist to discuss alternative treatment options. Do not stop taking your medication without consulting a medical professional.

Posted
Updated
Recall No.
D-0556-2026
Agency
Firm
Ascend Laboratories, LLC
Recall ID
98874
Status
ONGOING

Why it was recalled

Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, due to failed dissolution specifications where the Olmesartan Medoxomil content is below the required levels. This recall affects the 30-count bottle presentation.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-501-30.

UPC
24123460
Recall #
D-0556-2026

Where it was sold

Distributed nationwide.

Other recent recalls from Ascend Laboratories, LLC

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-06-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification